Personal information

Websites & social links

Google Scholar
Research Gate
Linkedin
Sciprofile

Other IDs

SciProfiles: 1752135

Keywords

Drug delivery, Pharmaceutical Product development, Nanomedicine, Product development for HIV and Contraception, Formulation development for Cancer, Biopharmaceutics and Pharmacokinetics, Oral Bioavailability Enhancement, Sterile injectable formulations, Liposome technology

Countries

India, United States

Biography

I am Nagavendra Kommineni, completed his master's and PhD in Pharmaceutics from NIPER Hyderabad, India. I worked as a Research Associate in Florida A&M University, Tallahassee, FL-USA, in department of pharmaceutical sciences. Currently I am working as a Research fellow in Population Council at Rockefeller University, New York, USA. My area of expertise includes Liposomal technology for delivering small molecules, Stem cell derived Exosome delivery of small molecules, Lipid nanoparticles, Topical and Transdermal product development and development of complex and sterile injectables, developing nanotechnology-based products for HIV and contraception. I Published more than 45 articles in a reputed international journals with aggregate impact factor of more than 100. total citations 2533, h-index: 17 and i10- index: 24. Google scholar link: https://scholar.google.co.in/citations?user=JGaaJlgAAAAJ

Activities

Collapse all

Employment (4)

Population Council: New York, NY, US

2021-04-05 to present | Research Fellow (Center for Biomedical Research)
Employment
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Florida Agricultural and Mechanical University: Tallahassee, Florida, US

2019-12-16 to 2021-04-04 | Research Associate (Pharmaceutical Sciences)
Employment
Source: Self-asserted source
NAGAVENDRA KOMMINENI

NATCO Pharma Limited: Hyderabad, Telangana, IN

2018-12-03 to 2019-12-12 | Executive (NDDS)
Employment
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Cipla Ltd: Mumbai, Maharashtra, IN

2014-10-10 to 2015-08-04 | Formulation Research Trainee (Injectables)
Employment
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Education and qualifications (2)

National Institute of Pharmaceutical Education and Research Hyderabad: Hyderabad, Telangana, IN

2015-08-05 to 2018-12-01 | Doctor of Philosophy (Pharmaceutics)
Education
Source: Self-asserted source
NAGAVENDRA KOMMINENI

National Institute of Pharmaceutical Education and Research Hyderabad: Hyderabad, Telangana, IN

2012-08-02 to 2014-06-25 | Masters (Pharmaceutics)
Education
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Works (42)

In Situ Photo Responsive Biodegradable Nanoparticle Forming Intrauterine Implant for Drug Delivery to Treat Ovarian Diseases: A Rationale-based Review

Current Radiopharmaceuticals
2024-12 | Journal article
DOI: 10.2174/0118744710258313231105072931
Contributors: Leander Corrie; Nagavendra Kommineni; Jaskiran Kaur; Ankit Awasthi; Raghunandan Gundaram; Latha Kukati
Source: check_circle
Crossref

Receptor-Targeted Nanomedicine for Cancer Therapy

Receptors
2024-07-03 | Journal article
DOI: 10.3390/receptors3030016
Contributors: Arvee Prajapati; Shagun Rangra; Rashmi Patil; Nimeet Desai; Vaskuri G. S. Sainaga Jyothi; Sagar Salave; Prakash Amate; Derajram Benival; Nagavendra Kommineni
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Special Issue “Latest Advances in Nanomedicine Strategies for Different Diseases”

International Journal of Molecular Sciences
2024-05-27 | Journal article
DOI: 10.3390/ijms25115835
Contributors: Nagavendra Kommineni; Veera Ganesh Yerra
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

HPMCAS-Based Amorphous Solid Dispersions in Clinic: A Review on Manufacturing Techniques (Hot Melt Extrusion and Spray Drying), Marketed Products and Patents

Materials
2023-10-10 | Journal article
DOI: 10.3390/ma16206616
Contributors: Leander Corrie; Srinivas Ajjarapu; Srikanth Banda; Madhukiran Parvathaneni; Pradeep Kumar Bolla; Nagavendra Kommineni
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Correction: Kalvala et al. Cannabidiol-Loaded Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Paclitaxel-Induced Peripheral Neuropathy. Pharmaceutics 2023, 15, 554

Pharmaceutics
2023-08-25 | Journal article
DOI: 10.3390/pharmaceutics15092200
Contributors: Anil Kumar Kalvala; Arvind Bagde; Peggy Arthur; Tanmay Kulkarni; Santanu Bhattacharya; Sunil Surapaneni; Nil Kumar Patel; Ramesh Nimma; Aragaw Gebeyehu; Nagavendra Kommineni et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Collagen-Based Hydrogels for the Eye: A Comprehensive Review

Gels
2023-08-09 | Journal article
DOI: 10.3390/gels9080643
Contributors: Dhwani Rana; Nimeet Desai; Sagar Salave; Bharathi Karunakaran; Jyotsnendu Giri; Derajram Benival; Srividya Gorantla; Nagavendra Kommineni
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

“Bioinspired” Membrane-Coated Nanosystems in Cancer Theranostics: A Comprehensive Review

Pharmaceutics
2023-06-08 | Journal article
DOI: 10.3390/pharmaceutics15061677
Contributors: Nimeet Desai; Dhwani Rana; Shreya Pande; Sagar Salave; Jyotsnendu Giri; Derajram Benival; Nagavendra Kommineni
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Versatility of Liposomes for Antisense Oligonucleotide Delivery: A Special Focus on Various Therapeutic Areas

Pharmaceutics
2023-05-08 | Journal article
DOI: 10.3390/pharmaceutics15051435
Contributors: Raghav Gupta; Sagar Salave; Dhwani Rana; Bharathi Karunakaran; Arun Butreddy; Derajram Benival; Nagavendra Kommineni
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications

Pharmaceutics
2023-04-21 | Journal article
DOI: 10.3390/pharmaceutics15041313
Contributors: Nimeet Desai; Dhwani Rana; Sagar Salave; Raghav Gupta; Pranav Patel; Bharathi Karunakaran; Amit Sharma; Jyotsnendu Giri; Derajram Benival; Nagavendra Kommineni
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

SNAC for Enhanced Oral Bioavailability: An Updated Review

Pharmaceutical Research
2023-03 | Journal article
DOI: 10.1007/s11095-022-03459-9
Contributors: Nagavendra Kommineni; Vaskuri G S Sainaga Jyothi; Arun Butreddy; Saka Raju; Tovi Shapira; Wahid Khan; Pavimol Angsantikul; Abraham J. Domb
Source: check_circle
Crossref

Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications

Vaccines
2023-03-15 | Journal article
DOI: 10.3390/vaccines11030661
Contributors: Bharathi Karunakaran; Raghav Gupta; Pranav Patel; Sagar Salave; Amit Sharma; Dhruv Desai; Derajram Benival; Nagavendra Kommineni
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis

Pharmaceutics
2023-02-11 | Journal article
DOI: 10.3390/pharmaceutics15020608
Contributors: Sagar Salave; Suchita Dattatray Shinde; Dhwani Rana; Bichismita Sahu; Hemant Kumar; Rikin Patel; Derajram Benival; Nagavendra Kommineni
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Cannabidiol-Loaded Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Paclitaxel-Induced Peripheral Neuropathy

Pharmaceutics
2023-02-07 | Journal article
DOI: 10.3390/pharmaceutics15020554
Contributors: Anil Kalvala; Arvind Bagde; Peggy Arthur; Tanmay Kulkarni; Santanu Bhattacharya; Sunil Surapaneni; Nil Patel; Ramesh Nimma; Aragaw Gebeyehu; Nagavendra Kommineni et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A Comprehensive Review of mRNA Vaccines

International Journal of Molecular Sciences
2023-01-31 | Journal article
DOI: 10.3390/ijms24032700
Contributors: Vrinda Gote; Pradeep Kumar Bolla; Nagavendra Kommineni; Arun Butreddy; Pavan Kumar Nukala; Sushesh Srivatsa Palakurthi; Wahid Khan
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies

Pharmaceuticals
2023-01-28 | Journal article
DOI: 10.3390/ph16020197
Contributors: Leander Corrie; Ankit Awasthi; Jaskiran Kaur; Sukriti Vishwas; Monica Gulati; Indu Pal Kaur; Gaurav Gupta; Nagavendra Kommineni; Kamal Dua; Sachin Kumar Singh
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Anabolic Peptide-Enriched Stealth Nanoliposomes for Effective Anti-Osteoporotic Therapy

Pharmaceutics
2022-11-09 | Journal article
DOI: 10.3390/pharmaceutics14112417
Contributors: Sagar Salave; Dhwani Rana; Hemant Kumar; Nagavendra Kommineni; Derajram Benival
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Polysaccharide Based Implantable Drug Delivery: Development Strategies, Regulatory Requirements, and Future Perspectives

Polysaccharides
2022-09-08 | Journal article
DOI: 10.3390/polysaccharides3030037
Contributors: Sagar Salave; Dhwani Rana; Amit Sharma; K. Bharathi; Raghav Gupta; Shubhangi Khode; Derajram Benival; Nagavendra Kommineni
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review

Materials
2022-08-05 | Journal article
DOI: 10.3390/ma15155392
Contributors: Fouad Damiri; Swetha Andra; Nagavendra Kommineni; Satheesh Kumar Balu; Raviteja Bulusu; Amira A. Boseila; Damilola O. Akamo; Zubair Ahmad; Farhat S. Khan; Md. Habibur Rahman et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

PLGA Nanoparticles in Drug Delivery

Nanoengineering of Biomaterials
2022-02-14 | Other
DOI: 10.1002/9783527832095.ch8
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges

Pharmaceuticals
2022-02-03 | Journal article
DOI: 10.3390/ph15020190
Contributors: Fouad Damiri; Nagavendra Kommineni; Samuel Ogbeide Ebhodaghe; Raviteja Bulusu; Vaskuri G. S. Sainaga Jyothi; Amany A. Sayed; Aeshah A. Awaji; Mousa O. Germoush; Hamdan S. Al-malky; Mohammed Z. Nasrullah et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Role of Exosomes for Delivery of Chemotherapeutic Drugs

Critical Reviews™ in Therapeutic Drug Carrier Systems
2021 | Journal article
DOI: 10.1615/critrevtherdrugcarriersyst.2021036301
Part of ISSN: 0743-4863
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models

International Journal of Pharmaceutics
2021-09 | Journal article
DOI: 10.1016/j.ijpharm.2021.120943
Part of ISSN: 0378-5173
Source: Self-asserted source
NAGAVENDRA KOMMINENI

PLGA/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein/Peptide Delivery

International Journal of Molecular Sciences
2021-08-18 | Journal article
DOI: 10.3390/ijms22168884
Part of ISSN: 1422-0067
Source: Self-asserted source
NAGAVENDRA KOMMINENI
grade
Preferred source (of 3)‎

Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives

Nanomaterials
2021-06-03 | Journal article
DOI: 10.3390/nano11061481
Part of ISSN: 2079-4991
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Lignin: Drug/Gene Delivery and Tissue Engineering Applications

International Journal of Nanomedicine
2021-03 | Journal article
DOI: 10.2147/IJN.S303462
Contributors: Raj Kumar; Arun Butreddy; Nagavendra Kommineni; Pulikanti Guruprasad Reddy; Naveen Bunekar; Chandrani Sarkar; Sunil Dutt; Vivek K Mishra; Keshaw Ram Aadil; Yogendra Kumar Mishra et al.
Source: check_circle
Crossref

Role of nano-lipid formulation of CARP-1 mimetic, CFM-4.17 to improve systemic exposure and response in osimertinib resistant non-small cell lung cancer

European Journal of Pharmaceutics and Biopharmaceutics
2021-01 | Journal article
DOI: 10.1016/j.ejpb.2020.11.007
Part of ISSN: 0939-6411
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products

International Journal of Pharmaceutics
2020-08 | Journal article
DOI: 10.1016/j.ijpharm.2020.119560
Part of ISSN: 0378-5173
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Enhanced penetration and improved therapeutic efficacy of bexarotene via topical liposomal gel in imiquimod induced psoriatic plaque model in BALB/c mice

Journal of Drug Delivery Science and Technology
2020-08 | Journal article
DOI: 10.1016/j.jddst.2020.101691
Part of ISSN: 1773-2247
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Antibody drug conjugates: Development, characterization, and regulatory considerations

Polymers for Advanced Technologies
2020-06 | Journal article
DOI: 10.1002/pat.4789
Part of ISSN: 1042-7147
Part of ISSN: 1099-1581
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Liposomal Drug Delivery System and Its Clinically Available Products

Handbook of Materials for Nanomedicine
2020-03-12 | Book chapter
DOI: 10.1201/9781003045076-4
Part of ISBN: 9781003045076
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment

Pharmaceutical Development and Technology
2020-01-02 | Journal article
DOI: 10.1080/10837450.2019.1567763
Part of ISSN: 1083-7450
Part of ISSN: 1097-9867
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancer

Chemistry and Physics of Lipids
2019-11 | Journal article
DOI: 10.1016/j.chemphyslip.2018.11.009
Part of ISSN: 0009-3084
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Preparation and Comparison of Oral Bioavailability for Different Nano-formulations of Olaparib

AAPS PharmSciTech
2019-10 | Journal article
DOI: 10.1208/s12249-019-1468-y
Part of ISSN: 1530-9932
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Edge activated ultradeformable liposomes of psoralen and its derivatives: Development and comparative evaluation for vitiligo therapy

Journal of Drug Delivery Science and Technology
2019-08 | Journal article
DOI: 10.1016/j.jddst.2019.02.033
Part of ISSN: 1773-2247
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model

Drug Development and Industrial Pharmacy
2019-05-04 | Journal article
DOI: 10.1080/03639045.2019.1576722
Part of ISSN: 0363-9045
Part of ISSN: 1520-5762
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects

Pharmaceutics
2019-03-25 | Journal article
DOI: 10.3390/pharmaceutics11030141
Part of ISSN: 1999-4923
Source: Self-asserted source
NAGAVENDRA KOMMINENI
grade
Preferred source (of 3)‎

Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer

Biomedicine & Pharmacotherapy
2019-02 | Journal article
DOI: 10.1016/j.biopha.2018.11.145
Part of ISSN: 0753-3322
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Cationic liposomes for co-delivery of paclitaxel and anti-Plk1 siRNA to achieve enhanced efficacy in breast cancer

Journal of Drug Delivery Science and Technology
2018-12 | Journal article
DOI: 10.1016/j.jddst.2018.09.017
Part of ISSN: 1773-2247
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Dendrimer as a new potential carrier for topical delivery of siRNA: A comparative study of dendriplex vs. lipoplex for delivery of TNF-α siRNA

International Journal of Pharmaceutics
2018-10 | Journal article
DOI: 10.1016/j.ijpharm.2018.08.024
Part of ISSN: 0378-5173
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Non-polymer drug-eluting coronary stents

Drug Delivery and Translational Research
2018-08 | Journal article
DOI: 10.1007/s13346-017-0414-3
Part of ISSN: 2190-393X
Part of ISSN: 2190-3948
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy

Pharmacological Research
2017-12 | Journal article
DOI: 10.1016/j.phrs.2017.05.010
Part of ISSN: 1043-6618
Source: Self-asserted source
NAGAVENDRA KOMMINENI

Liposomal Formulations in Clinical Use: An Updated Review

Pharmaceutics
2017-03-27 | Journal article
DOI: 10.3390/pharmaceutics9020012
Part of ISSN: 1999-4923
Source: Self-asserted source
NAGAVENDRA KOMMINENI
grade
Preferred source (of 3)‎

Peer review (38 reviews for 13 publications/grants)

Review activity for Advanced healthcare materials (1)
Review activity for Applied materials today. (2)
Review activity for Biochemical and biophysical research communications. (1)
Review activity for Biomedicine & pharmacotherapy. (2)
Review activity for Cancers. (1)
Review activity for Coordination chemistry reviews (1)
Review activity for International journal of biological macromolecules. (15)
Review activity for International journal of pharmaceutics (4)
Review activity for Journal of drug delivery science and technology. (7)
Review activity for Journal of Pharmaceutical Analysis. (1)
Review activity for Materials today communications. (1)
Review activity for Materials today. (1)
Review activity for Saudi pharmaceutical journal. (1)
How many people are using ORCID?